CTRI/2023/12/060748尚未招募2 期
Efficacy and safety profile of Vortioxetine as an add-on molecule in Obsessive-Compulsive Disorder; A Randomized Double-Blinded Placebo-Controlled Superiority Trial - Not applicable
Indican Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i. Patients diagnosed with OCD as per ICD 11 by a psychiatrist
- •ii. OCD rated as moderate to severe (YBOCS score 16+)
- •iii. Patients who are drug naïve or have not taken any SRIs for the last 7 days at least.
排除标准
- •i. Patients with psychotic symptoms
- •ii. Patients with co-morbid major psychiatric illness
- •iii. Patients with comorbid substance use disorder in dependence pattern except tobacco
- •and caffeine.
- •iv. Pregnant and lactating mothers.
- •v. Patients with co-morbid medical or neurological illness
- •vi. Patients with history of adverse drug reaction to Vortioxetine in the past
研究者
相似试验
招募中
不适用
Relationship between the effects of vortioxetine and sleep EEG findings in depressioDepressionJPRN-UMIN000047036ihon University Itabashi Hospital30
招募中
4 期
Real-life effectiveness of vortioxetine on goal achievement and work productivity for patients with major depressive disorder in JapaMajor depressive disorderJPRN-jRCT1031210200Hongo Seiji120
已完成
2 期
Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With DepressionMajor Depressive DisorderNCT03766867H. Lundbeck A/S80
尚未招募
4 期
Study on Vortioxetine vs Fluoxetine in the treatment of DepressioCTRI/2023/09/057558Government Medical College and Hospital
已完成
3 期
Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderDepressive Disorder, MajorNCT01153009Takeda614